Marvel Biosciences Corp's total assets for Q1 2025 were C$228.65K, a decrease of -53.46% from the previous quarter. TSE:MRVL total liabilities were C$3.31M for the fiscal quarter, a -0.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.